Floatz logo

Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter

Peripheral T Cell Lymphoma

Mayo ClinicvaccinePhase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
73/ 100

Competitive context

52 Active assets in the Peripheral T Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Tucidinostat
Ruijin Hospital
Phase 4BB
shr2554
Sun Yat-sen University
Phase 3BB
DEXAMETHASONE
Ou Bai, MD/PHD
Phase 4BB
Ifosfamide
New York Medical College
Phase 4BB
CIS-DIAMMINEDICHLOROPLATINUM II
Ou Bai, MD/PHD
Phase 4BB

View all 50 →

Same molecule, other indications

Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter is also rated in:

Advanced Clear Cell Renal Cell CarcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
Stage III Renal Cell Cancer AJCC v8Dormant
CCC
Indicative ·
53 / 100
View asset →
Recurrent Adult Acute Myeloid LeukemiaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →